Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has appointed Mark DaFonseca as its Chief Commercial Officer.  A seasoned CDMO and pharmaceutical services executive, DaFonseca has nearly 30 years of pharmaceutical industry experience spanning all aspects of drug development from preclinical and chemistry, manufacturing and controls (CMC) activities through late-stage clinical trials. Notably, over the past 15 years, he has established a...